<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7284144\results\search\disease\results.xml">
  <result pre="of Microbial Metabolism, School of Life Sciences and Biotechnology, and" exact="Joint" post="Laboratory of International Cooperation in Metabolic and Developmental Sciences,"/>
  <result pre="Biotechnology, and Joint Laboratory of International Cooperation in Metabolic and" exact="Developmental" post="Sciences, Ministry of Education, Shanghai Jiao Tong UniversityChina[c], Department"/>
  <result pre="Laboratory, Veterinary Research Institute, PeshawarPakistan[e], College of Life Sciences, Chongqing" exact="Normal" post="UniversityChina[f], Peng Cheng LaboratoryChina CONTACT Dong-Qing Wei dqwei@sjtu.edu.cn State"/>
  <result pre="of Microbial Metabolism, School of Life Sciences and Biotechnology, and" exact="Joint" post="Laboratory of International Cooperation in Metabolic and Developmental Sciences,"/>
  <result pre="Biotechnology, and Joint Laboratory of International Cooperation in Metabolic and" exact="Developmental" post="Sciences, Ministry of Education, Shanghai Jiao Tong University, 800"/>
  <result pre="Europe PMC, consistent with existing copyright protections.TBSD_A_1769733.pdf Abstract Abstract Sever" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded RNA"/>
  <result pre="PMC, consistent with existing copyright protections.TBSD_A_1769733.pdf Abstract Abstract Sever acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded RNA (ssRNA)"/>
  <result pre="consistent with existing copyright protections.TBSD_A_1769733.pdf Abstract Abstract Sever acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) is a single-stranded RNA (ssRNA) virus,"/>
  <result pre="(SARS-CoV-2) is a single-stranded RNA (ssRNA) virus, responsible for severe" exact="acute" post="respiratory disease (COVID-19). A large number of natural compounds"/>
  <result pre="is a single-stranded RNA (ssRNA) virus, responsible for severe acute" exact="respiratory" post="disease (COVID-19). A large number of natural compounds are"/>
  <result pre="a single-stranded RNA (ssRNA) virus, responsible for severe acute respiratory" exact="disease" post="(COVID-19). A large number of natural compounds are under"/>
  <result pre="trial for screening compounds, possessing potential inhibitory effect against the" exact="viral infection." post="Keeping in view the importance of marine compounds in"/>
  <result pre="structure of Mpro in an apo form was retrieved from" exact="Protein" post="Data Bank and marine compounds from PubChem. These structures"/>
  <result pre="many hydrogen and hydrophobic interactions. The C-1 also attained a" exact="stable" post="dynamic behavior, and the average distance between compound and"/>
  <result pre="Commission of Shanghai Municipality Natural Science Foundation of Henan Province" exact="Joint" post="Research Funds for Medical and Engineering and Scientific Research"/>
  <result pre="19430750600), the Natural Science Foundation of Henan Province (162300410060), and" exact="Joint" post="Research Funds for Medical and Engineering and Scientific Research"/>
  <result pre="page-count: word-count: 1. Introduction Coronavirus pandemic-19 (COVIDâ€‘19) is an ongoing" exact="disease" post="caused by severe acute respiratory syndrome (SARS-CoV-2). According to"/>
  <result pre="Coronavirus pandemic-19 (COVIDâ€‘19) is an ongoing disease caused by severe" exact="acute" post="respiratory syndrome (SARS-CoV-2). According to the WHO latest report,"/>
  <result pre="pandemic-19 (COVIDâ€‘19) is an ongoing disease caused by severe acute" exact="respiratory" post="syndrome (SARS-CoV-2). According to the WHO latest report, 3,442,234"/>
  <result pre="(COVIDâ€‘19) is an ongoing disease caused by severe acute respiratory" exact="syndrome" post="(SARS-CoV-2). According to the WHO latest report, 3,442,234 are"/>
  <result pre="been reported from Europe (1,544,145) followed by Americas (1,433,756), Eastern" exact="Mediterranean" post="(211,555), Western Pacific (152,774), South-East Asia (68,756), and Africa"/>
  <result pre="infected a large population of people around the world (Coronavirus" exact="Disease" post="2019 (COVID-19) Situation Report-35, n.d.). The SARS-CoV-2, previously known"/>
  <result pre="as compared with previous coronaviruses (SARS-CoV and MERS-CoV) with the" exact="absence of" post="therapeutic agents (Heymann etÂ al., 2020; Zhang &amp;amp; Liu,"/>
  <result pre="Mayer etÂ al., 2019). Further, a possible vaccine target is" exact="viral" post="structural proteins, the development of which is desirable and"/>
  <result pre="meantime, however, a great effort involves the targeting of nonstructural" exact="viral" post="proteins which are instead essential for the viral replication"/>
  <result pre="of nonstructural viral proteins which are instead essential for the" exact="viral" post="replication and the maturation processes, representing a specific target"/>
  <result pre="into long chains of proteins, producing more copies. These long" exact="viral" post="proteins are activated when cut into smaller pieces by"/>
  <result pre="are activated when cut into smaller pieces by proteases. Hence," exact="viral" post="proteases have a critical role in the propagation of"/>
  <result pre="might be useful against COVID-19. 2. Material and methods 2.1." exact="Protein" post="preparation The recently submitted crystal structure of COVID-19 Mpro"/>
  <result pre="(PDB ID: 6M03; Berman etÂ al., 2000) was extracted from" exact="Protein" post="Data Bank. The structure was subjected to preparation by"/>
  <result pre="Protein Data Bank. The structure was subjected to preparation by" exact="Protein" post="Preparation Wizard in molecular operating environment (MOE; Vilar etÂ"/>
  <result pre="Vilar etÂ al., 2008). The missing hydrogens were added, and" exact="partial" post="charges were assigned. 2.2. Ligand preparation The 2â€‰D structures"/>
  <result pre="specified and centered using 20â€‰Ã—â€‰20â€‰Ã—â€‰20 with 0.375 grid spacing. A" exact="total" post="of 50 runs were performed to observe a wide"/>
  <result pre="with a time gap of 2 fs to achieve a" exact="stable" post="state. To maintains a constant temperature inside the box,"/>
  <result pre="2013). Radius of gyration (Rg) was calculated to infer the" exact="stable" post="protein folding. 2.5. ADME prediction To analyze the pharmacodynamics"/>
  <result pre="(Table 1) have been docked in the crystal structure of" exact="viral" post="Mpro. The compounds (Figure 1) exhibited a good interaction"/>
  <result pre="Mpro. The compounds (Figure 1) exhibited a good interaction with" exact="viral" post="Mpro, forming many hydrogen bonds (Figure 2). The ADME"/>
  <result pre="oral pharmacokinetics. In some cases, including HCV NS3/4A protease, and" exact="hepatitis C" post="virus (HCV) NS5A inhibitors the Lipinskiâ€™s rule of five"/>
  <result pre="previous study (Felix etÂ al., 2017), active against latent Mycobacterium" exact="tuberculosis" post="isolates. The drug has been observed as potent against"/>
  <result pre="20 years, SARS and MERS have been found as new" exact="infectious" post="agents, emerged to cause epidemics (de Wit etÂ al.,"/>
  <result pre="died in many epidemics, broken out over the centuries. Some" exact="infections" post="have been found, more deadly, especially viral pathogens. These"/>
  <result pre="the centuries. Some infections have been found, more deadly, especially" exact="viral" post="pathogens. These pathogens have resisted in majority of cases"/>
  <result pre="medical treatment. Synthesizing drugs against rapidly replicated viruses resulting in" exact="acute" post="syndromes is a laborious and time-consuming procedure, requires a"/>
  <result pre="drug-likeness with high degrees of bioavailability, and effective drugs against" exact="viral" post="diseases shortly. Mpro (3CLpro) monomer has three domains: domain"/>
  <result pre="Shen, 2009). SARS-CoV-2 Mpro in complexed with C1 exhibited a" exact="stable" post="RMSD between 0.2 and 0.45â€‰nm (Figure 5) and the"/>
  <result pre="in the significance difference (0.2 and 0.3â€‰nm). This shows a" exact="stable" post="binding of C1 with Mpro that might be a"/>
  <result pre="Mpro in complex with C1 compound. The complex exhibited a" exact="stable" post="RMSD and RMSF during a 100â€‰ns MD simulation period."/>
  <result pre="folding (Lobanov etÂ al., 2008; Smilgies &amp;amp; Folta-Stogniew, 2015). A" exact="stable" post="Rg value shows compactness and stable folding maintains a"/>
  <result pre="&amp;amp; Folta-Stogniew, 2015). A stable Rg value shows compactness and" exact="stable" post="folding maintains a steady value of Rg, required for"/>
  <result pre="BhatT. N., WeissigH., ShindyalovI. N., &amp;amp; BourneP. E. (2000). The" exact="Protein" post="Data Bank. Nucleic Acids Research, 28(1), 235â€&quot;242. 10.1093/nar/28.1.23510592235 BernardiA.,"/>
  <result pre="coronavirus by computational approaches In LendeckelU. &amp;amp; HooperN. M. (Eds.)," exact="Viral" post="proteases and antiviral protease inhibitor therapy: Proteases in biology"/>
  <result pre="proteases and antiviral protease inhibitor therapy: Proteases in biology and" exact="disease" post="(pp. 1â€&quot;23). Springer10.1007/978-90-481-2348-3_1 ChuL.-H M., ChoyW.-Y., TsaiS.-N., RaoZ., &amp;amp;"/>
  <result pre="(2006). Rapid peptide-based screening on the substrate specificity of severe" exact="acute" post="respiratory syndrome (SARS) coronavirus 3C-like protease by matrix-assisted laser"/>
  <result pre="Rapid peptide-based screening on the substrate specificity of severe acute" exact="respiratory" post="syndrome (SARS) coronavirus 3C-like protease by matrix-assisted laser desorption/ionization"/>
  <result pre="peptide-based screening on the substrate specificity of severe acute respiratory" exact="syndrome" post="(SARS) coronavirus 3C-like protease by matrix-assisted laser desorption/ionization time-of-flight"/>
  <result pre="coronavirus 3C-like protease by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry." exact="Protein" post="Science: A Publication of the Protein Society, 15(4), 699â€&quot;709."/>
  <result pre="desorption/ionization time-of-flight mass spectrometry. Protein Science: A Publication of the" exact="Protein" post="Society, 15(4), 699â€&quot;709. 10.1110/ps.052007306 [pubmedMismatch]7ConnollyM. L. (1993). The molecular"/>
  <result pre="package. Journal of Molecular Graphics, 11(2), 139â€&quot;141. 10.1016/0263-7855(93)87010-3 collab: Coronavirus" exact="disease" post="2019 (COVID-19) Situation Report-35 (n.d.). Retrieved February 26, 2020,"/>
  <result pre="drug discovery. Metabolites, 2(2), 303â€&quot;336. 10.3390/metabo202030324957513 DoniachS., &amp;amp; EastmanP. (1999)." exact="Protein" post="dynamics simulations from nanoseconds to microseconds. Current Opinion in"/>
  <result pre="Protein dynamics simulations from nanoseconds to microseconds. Current Opinion in" exact="Structural" post="Biology, 9(2), 157â€&quot;163. 10.1016/S0959-440X(99)80022-010322213 DubeyK. D., TiwariR. K., &amp;amp;"/>
  <result pre="DiazM. C., ReedJ. K., WrightA. E., &amp;amp; RohdeK. H. (2017)." exact="Selective" post="killing of dormant mycobacterium tuberculosis by marine natural products."/>
  <result pre="E., &amp;amp; RohdeK. H. (2017). Selective killing of dormant mycobacterium" exact="tuberculosis" post="by marine natural products. Antimicrobial Agents and Chemotherapy, 61(8),"/>
  <result pre="two decades: The story of SARS, MERS, and Now COVID-19." exact="American" post="Journal of Clinical Pathology, 153(4), 420â€&quot;421. 10.1093/ajcp/aqaa02932053148 GuptaM. K.,"/>
  <result pre="(2020). In-silico approaches to detect inhibitors of the human severe" exact="acute" post="respiratory syndrome coronavirus envelope protein ion channel. Journal of"/>
  <result pre="In-silico approaches to detect inhibitors of the human severe acute" exact="respiratory" post="syndrome coronavirus envelope protein ion channel. Journal of Biomolecular"/>
  <result pre="approaches to detect inhibitors of the human severe acute respiratory" exact="syndrome" post="coronavirus envelope protein ion channel. Journal of Biomolecular Structure"/>
  <result pre="ShindoN, &amp;amp; collab: WHO Scientific and Technical Advisory Group for" exact="Infectious" post="Hazards (2020). COVID-19: What is next for public health?The"/>
  <result pre="in ESR1 as a mechanism of resistance to drugs in" exact="breast cancer" post="cell lines. Frontiers in Molecular Biosciences, 610.3389/fmolb.2019.00159 KhanM. T.,"/>
  <result pre="ESR1 as a mechanism of resistance to drugs in breast" exact="cancer" post="cell lines. Frontiers in Molecular Biosciences, 610.3389/fmolb.2019.00159 KhanM. T.,"/>
  <result pre="ManickamM., NamasivayamV., HayashiY., collab: &amp;amp;JungS.-H. (2016). An overview of severe" exact="acute" post="respiratory syndrome-coronavirus (SARS-CoV) 3CL protease inhibitors: Peptidomimetics and small"/>
  <result pre="NamasivayamV., HayashiY., collab: &amp;amp;JungS.-H. (2016). An overview of severe acute" exact="respiratory" post="syndrome-coronavirus (SARS-CoV) 3CL protease inhibitors: Peptidomimetics and small molecule"/>
  <result pre="&amp;amp; MenakhaM. (2015). Pharmaceutical applications of cyanobacteriaâ€&quot;A review. Journal of" exact="Acute" post="Medicine, 5(1), 15â€&quot;23. 10.1016/j.jacme.2015.02.004 VilarS., CozzaG., &amp;amp; MoroS. (2008)."/>
  <result pre="BartlamM., HilgenfeldR., &amp;amp; RaoZ. (2003). The crystal structures of severe" exact="acute" post="respiratory syndrome virus main protease and its complex with"/>
  <result pre="HilgenfeldR., &amp;amp; RaoZ. (2003). The crystal structures of severe acute" exact="respiratory" post="syndrome virus main protease and its complex with an"/>
  <result pre="&amp;amp; RaoZ. (2003). The crystal structures of severe acute respiratory" exact="syndrome" post="virus main protease and its complex with an inhibitor."/>
  <result pre="LiuY. (2020). Potential interventions for novel coronavirus in China: A" exact="systemic" post="review. Journal of Medical Virology, 92(5), 479â€&quot;490. 10.1002/jmv.2570732052466 ZhengX.,"/>
  <result pre="228â€&quot;241. 10.1208/s12248-012-9426-623180158 Abbreviations ADME adsorption, distribution, metabolism and excretion HCV" exact="Hepatitis" post="C virus MD molecular dynamic simulations MPro Main protease"/>
  <result pre="dynamic simulations MPro Main protease MOE molecular operating environment PDB" exact="Protein" post="Data Bank RMSD Root mean square deviation, Rg radius"/>
  <result pre="Rg radius of gyration RMSF root mean square fluctuation SARS-CoV-2" exact="Severe" post="acute respiratory syndrome coronavirus-2"/>
  <result pre="radius of gyration RMSF root mean square fluctuation SARS-CoV-2 Severe" exact="acute" post="respiratory syndrome coronavirus-2"/>
  <result pre="of gyration RMSF root mean square fluctuation SARS-CoV-2 Severe acute" exact="respiratory" post="syndrome coronavirus-2"/>
  <result pre="gyration RMSF root mean square fluctuation SARS-CoV-2 Severe acute respiratory" exact="syndrome" post="coronavirus-2"/>
 </snippets>
</snippetsTree>
